Conjunctiva
Recognizing conjunctival chalasis avoids dry eye misdiagnosis
WAIKOLOA, Hawaii — Recognizing conjunctival chalasis depends on listening to the patient’s symptoms and investigating any report of a specific site of discomfort or foreign body sensation, a speaker said.“Conjunctival chalasis occurs when there is a degeneration of Tenon’s fascia that ordinarily tethers the bulbar conjunctiva to the globe,” OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, said at Hawaiian Eye 2013. “This allows stretching and redundancy of the conjunctiva, which bunches up at the inferior lid margin, and sometimes elsewhere, and causes a foreign body sensation especially when the patient blinks.”
“Preservative Toxicity a Disease,” Reports Working Group on Glaucoma Medication Preservatives Toxicity
Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC, announced that the Working Group on Preservatives Toxicity in Glaucoma Medications, an advisory panel of glaucoma treatment experts, was recently convened as an ongoing group to examine the issue of preservatives in glaucoma medications from an evidence-based perspective. The Working Group is sponsored by Valeant Ophthalmics. At its first roundtable, the Working Group discussed the interface between ocular surface dise...
New Dry Eye Treatments in the Pipeline
OSN: Several promising treatments are in the pipeline for dry eye, which is an “epidemic” and can drive patients to drink. Secretagogues stimulate the eye to produce its own tears, like Restasis. One is called Lancovutide which was originally used in cystic fibrosis. Rebamipide’s mechanism is to increase the mucin level in tears, which makes the tears more stable and less prone to evaporate. A company called Mimetogen is promoting a nerve growth (Read more...)
InSite Vision Updates Special Protocol Assessment Submission To FDA For Phase 3 Trial Of AzaSite Plus™ And DexaSite™
InSite Vision Incorporated (OTCBB:INSV) today announced that the Company recently received eight minor recommendations regarding its proposed agreement with the U.S...
Can Ocular Surface Squamous Neoplasia be Treated With Inteferon?
The December 2010 issue of Ophthalmology reports on a retrospective study of 14 patients finding that subconjunctival recombinant interferon alpha 2b may be a viable medical alternative for the treatment of ocular surface squamous neoplasia.
Eye Allergies Often Overlooked, Undertreated
Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16.
New Surgical Technique For Conjunctivochalasis?
Dr. Choi describes a very simple method in Ophthalmology of getting good results treating conjunctivochalasis.
Atopic Keratoconjunctivitis and Atopic Dermatitis
Severe atopic keratoconjunctivitis can cause blindness if it’s not diagnosed and treated in time.
Current Opinion in Allergy and Clinical Immunology
Current Opinion in Allergy and Clinical Immunology
Treatment of Seasonal Allergic Conjunctivitis With Ophthalmic Corticosteroids: In Search of the Perfect Ocular Corticosteroids in the Treatment of Allergic Conjunctivitis
Learn more about the newer ophthalmic corticosteroid formulations for conjunctivitis and their improved safety profile.
Current Opinion in Allergy and Clinical Immunology
Current Opinion in Allergy and Clinical Immunology
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma
New structured abstract in the Database of Abstracts of Reviews of Effects from the Centre for Reviews and Dissemination
Subscribe
